Keywords: fda, backs, new, zithromax, regimen, acute, otitis

FDA backs new Zithromax regimen for acute otitis media

Article | 08 November 2001

Print This

Pfizer says that a US Food and Drug Administration panel hasrecommended approval of its Zithromax (azithromycin) as both a single-dose ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in